Ezetimibe (EZ)/Atorvastatin (Ator) (MK-0653C) vs. Ator in Chinese Hypercholesterolemic Participants (MK-0653C-439)
Condition: Hypercholesterolemia Interventions: Combination Product: EZ 10 mg/Ator 10 mg; Combination Product: EZ 10 mg/Ator 20 mg; Drug: Atorvastatin; Drug: Placebo for FDC EZ/Ator; Drug: Placebo for atorvastatin Sponsor: Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Atorvastatin Calcium | China Health | Lipitor | Research | Statin Therapy | Vytorin | Zetia | Zivast